abstract |
The present invention relates generally to peptidomimetic compounds which inhibit Aminopeptidase P and their use in treating disorders and diseases associated with aberrant peptidase activity. More particularly, the present invention relates to peptidomimetic compounds comprising a β-amino acid. The peptidomimetic compounds of the invention may be useful in a range of therapeutic, prophylactic and diagnostic applications. |